Pubblicazioni
Renna LV, Bertani F, Podio A, Boveri S, Carrara M, Pinton A, Milani V, Spuria G, Nizza AF, Basilico S, et al (2023): Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers. Vaccines; 11: 463.
Malavazos AE, Basilico S, Iacobellis G, Milani V, Cardani R, Boniardi F, Dubini C, Prandoni I, Capitanio G, Renna LV, Boveri S, Rigolini R, Carrara M, Spuria G, Cuppone T, D’acquisto A, Carpinelli L, Sacchi M, Morricone L, Secchi F, Costa E, Menicanti L, Nisoli E, Carruba M, Ambrogi F, Corsi Romanelli MM (2022): Antibody responses to BNT162b2 mRNA vaccine: Infection-naïve individuals with abdominal obesity warrant attention. Obesity (Silver Spring); 30(3): 606.
Cavalli M, Cardani R, Renna LV, Toffetti M, Villa L, Meola G (2021): First Family of MATR3-Related Distal Myopathy From Italy: The Role of Muscle Biopsy in the Diagnosis and Characterization of a Still Poorly Understood Disease. Front Neurol; 12: 715386.
Sitzia C, Pistelli L, Cardani R, Renna LV, Ranucci M, Carrara M, Borlini S, Clerici P, Rampoldi B, Cornetta M, Corsi-Romanelli M (2021): Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter? J Biol Regul Homeost Agents; 35(3): 881.
Bosè F, Renna LV, Fossati B, Arpa G, Labate V, Milani V, Botta A, Micaglio E, Meola G, Cardani R (2019): TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2. Front Neurol; 10: 992.
Voellenkle C, Perfetti A, Carrara M, Fuschi P, Renna LV, Longo M, Sain SB, Cardani R, Valaperta R, Silvestri G, Legnini I, Bozzoni I, Furling D, Gaetano C, Falcone G, Meola G, Martelli F (2019): Dysregulation of Circular RNAs in myotonic dystrophy type 1. Int J Mol Sci; 20(8): E1938.
Renna LV, Bosé F, Brigonzi E, Fossati B, Meola G, Cardani R (2019): Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies. PLoS One; 14(3): e0214254.
Binda A, Renna LV, Bosé F, Brigonzi E, Botta A, Valaperta R, Fossati B, Rivolta I, Meola G, Cardani R (2018): SCN4A as modifier gene in patients with myotonic dystrophy type 2. Sci Rep; 8(1): 11058.
Cappella M, Perfetti A, Cardinali B, Garcia-Manteiga JM, Carrara M, Provenzano C, Fuschi P, Cardani R, Renna LV, Meola G, Falcone G, Martelli F (2018): High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2. Cell Death Dis; 9(7): 729.
Renna LV, Bosé F, Iachettini S, Fossati B, Saraceno L, Milani V, Colombo R, Meola G, Cardani R (2017): Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle. PLoS One; 12(9): e0184987.
Renna LV, Cardani R, Botta A, Rossi G, Fossati B, Costa E, Meola G (2014): Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction. Eur J Histochem; 58 (4): 2444.
Cardani R, Giagnacovo M, Rossi G, Renna LV, Bugiardini E, Pizzamiglio C, Botta A, Meola G (2014): Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2. Neuromuscular Disorders; 24 (12): 1042-53.
Cardani R, Bugiardini E, Renna LV, Rossi G, Colombo G, Valaperta R, Novelli G, Botta A, Meola G (2013): Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2. PLoS One; 8 (12): e83777.
Cardani R, Giagnacovo M, Botta A, Rinaldi F, Morgante A, Udd B, Raheem O, Penttila S, Suominen T, Renna LV, Sansone V, Bugiardini E, Novelli G, Meola G (2012): Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2. J.Neurology; 259(10), 2090-2099.
Malatesta M, Giagnacovo M, Renna LV, Cardani R, Meola G, Pellicciari C (2011): Cultured
myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence. Eur.J.Histochem; 55(3), e26.
